4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-036104
Chief Executive Officer sold 771 shares at $162.66 ($125,411)
- Chief Executive Officer acquired 24,571 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Saxonov Serge · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-19 | Grant or award : show line 1 in the form | +24,571 | 905,039 | D | ||
| 2021-05-24 | Sale : show line 2 in the form | −771 | $162.66 | $125,411 | 904,268 | D |
| Open-market sales · 771 sh · avg $162.66 · $125,411 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-19 | Grant or award : show line 3 in the form Stock Option (right to buy) | +61,428 | $177.76 | 2031-03-19 | 61,428 | 61,428 | D |
Loading xslF345X03/doc4.xml…